Top

10-04-2016 | Systemic lupus erythematosus | Book Chapter | Article

5. Autoantibodies and Biomarkers: Diagnostic Aspects

Authors: Savino Sciascia, Maria Laura Bertolaccini

Publisher: Springer International Publishing

Abstract

Autoantibodies, traditionally the hallmark of systemic lupus erythematosus (SLE), are typically present several years prior to diagnosis of SLE and serve as markers for future disease development in otherwise normal individuals. The methods for detecting autoantibodies play a crucial role in the diagnosis of SLE, as the particular assay used remarkably influences the interpretation of the test. In this chapter, we offer the reader an overview of the autoantibodies most commonly used in routine clinical practice.

Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349(16):1526–1533CrossRefPubMed

Scofield RH (2004) Autoantibodies as predictors of disease. Lancet 363(9420):1544–1546CrossRefPubMed

Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277CrossRefPubMed

Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725CrossRefPubMed

Kurien BT, Scofield RH (2003) Protein blotting: a review. J Immunol Methods 274(1–2):1–15CrossRefPubMed

Kurien BT, Scofield RH (2006) Western blotting. Methods 38(4):283–293CrossRefPubMed

Egner W (2000) The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 53(6):424–432CrossRefPubMedPubMedCentral

van Venrooij WJ, Charles P, Maini RN (1991) The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 140(2):181–189CrossRefPubMed

Yamamoto H, Sekiguchi T, Itagaki K, Saijo S, Iwakura Y (1993) Inflammatory polyarthritis in mice transgenic for human T cell leukemia virus type I. Arthritis Rheum 36(11):1612–1620CrossRefPubMed

10.

Kurien BT, Scofield RH (2006) Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 64(3):227–235CrossRefPubMed

11.

Emlen W, O’Neill L (1997) Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. Arthritis Rheum 40(9):1612–1618CrossRefPubMed

12.

Froelich CJ, Wallman J, Skosey JL, Teodorescu M (1990) Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB). J Rheumatol 17(2):192–200PubMed

13.

Bohan A (1979) Seronegative systemic lupus erythematosus. J Rheumatol 6(5):534–540PubMed

14.

Schur PH, Sandson J (1968) Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 278(10):533–538CrossRefPubMed

15.

Aarden LA, de Groot ER, Feltkamp TE (1975) Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 254:505–515CrossRefPubMed

16.

Brinkman K, Termaat R, Van den Brink H, Berden J, Smeenk R (1991) The specificity of the anti-dsDNA ELISA. A closer look. J Immunol Methods 139(1):91–100CrossRefPubMed

17.

Pan N, Amigues I, Lyman S, Duculan R, Aziz F, Crow MK et al (2014) A surge in anti-dsDNA titer predicts a severe lupus flare within six months. Lupus 23(3):293–298CrossRefPubMed

18.

Brito-Zeron P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA (2015) The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 11(5):301–312CrossRefPubMed

19.

Maddison PJ, Skinner RP, Vlachoyiannopoulos P, Brennand DM, Hough D (1985) Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera. Clin Exp Immunol 62(2):337–345PubMedPubMedCentral

20.

Hoch SO, Eisenberg RA, Sharp GC (1999) Diverse antibody recognition patterns of the multiple Sm-D antigen polypeptides. Clin Immunol 92(2):203–208CrossRefPubMed

21.

Jaekel HP, Klopsch T, Benkenstein B, Grobe N, Baldauf A, Schoessler W et al (2001) Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83-119 peptide in systemic lupus erythematosus and other autoimmune diseases. J Autoimmun 17(4):347–354CrossRefPubMed

22.

Lyons R, Narain S, Nichols C, Satoh M, Reeves WH (2005) Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease. Ann N Y Acad Sci 1050:217–228CrossRefPubMed

23.

Sawalha AH, Harley JB (2004) Antinuclear autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 16(5):534–540CrossRefPubMed

24.

Xiao X, Chang C (2014) Diagnosis and classification of drug-induced autoimmunity (DIA). J Autoimmun 48–49:66–72CrossRefPubMed

25.

Gerli R, Caponi L (2005) Anti-ribosomal P protein antibodies. Autoimmunity 38(1):85–92CrossRefPubMed

26.

Sciascia S, Bertolaccini ML, Roccatello D, Khamashta MA, Sanna G (2014) Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review. J Neurol 261(9):1706–1714CrossRefPubMed

27.

Sato T, Uchiumi T, Ozawa T, Kikuchi M, Nakano M, Kominami R et al (1991) Autoantibodies against ribosomal proteins found with high frequency in patients with systemic lupus erythematosus with active disease. J Rheumatol 18(11):1681–1684PubMed

28.

Giles I, Putterman C (2008) Autoantibodies and other biomarkers – pathological consequences (1). Lupus 17(3):241–246CrossRefPubMed

29.

Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA (2005) Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 64(3):444–448CrossRefPubMedPubMedCentral

30.

Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F (1991) IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 18(2):230–234PubMed

31.

Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Fremeaux-Bacchi V et al (2006) High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc 21(11):3115–3121

32.

Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA (1999) Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum 42(1):187–188CrossRefPubMed

33.

Bock M, Heijnen I, Trendelenburg M (2015) Anti-C1q antibodies as a follow-up marker in SLE patients. PLoS One 10(4):e0123572CrossRefPubMedPubMedCentral

34.

Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T et al (2011) Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Arthritis Rheum 63(8):2436–2444CrossRefPubMed

35.

Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R et al (2014) 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 13(9):917–930CrossRefPubMed

36.

Court E (1997) Lupus anticoagulants: pathogenesis and laboratory diagnosis. Br J Biomed Sci 54:287–298PubMed

37.

Worrall JG, Snaith ML, Batchelor JR, Isenberg DA (1990) SLE: a rheumatologic view. Analysis of the clinical features, serology, and immunogenetics in 100 SLE patients during long-term follow-up. Q J Med 74:319–330PubMed

38.

Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74:1185–1190PubMed

39.

Greaves M, Cohen H, MacHin SJ, Mackie I (2000) Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 109(4):704–715CrossRefPubMed

40.

Urbanus RT, Derksen RH, de Groot PG (2008) Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev 22:93–105CrossRefPubMed

41.

Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S et al (1983) Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet ii(8361):1211–1214CrossRef

42.

Roubey RA (1994) Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other antiphospholipid autoantibodies. Blood 84(9):2854–2867PubMed

43.

Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN (1985) Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 62(3):738–745PubMedPubMedCentral

44.

Manoussakis MN, Gharavi AE, Drosos AA, Kitridou RC, Moutsopoulos HM (1987) Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol 44(3):297–307CrossRefPubMed

45.

Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR (1988) Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 15(1):74–79PubMed

46.

Meyer O, Cyna L, Bourgeois P, Kahn MF, Ryckewaert A (1987) Profile and cross-reactivities of antiphospholipid antibodies in systemic lupus erythematosus and syphilis. Clin Rheumatol 6(3):369–377CrossRefPubMed

47.

Nahass GT (1997) Antiphospholipid antibodies and the antiphospholipid antibody syndrome. J Am Acad Dermatol 36(2 Pt 1):149–168; quiz 69–72CrossRefPubMed

48.

Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 112(9):682–698CrossRefPubMed

49.

Meijide H, Sciascia S, Sanna G, Khamashta MA, Bertolaccini ML (2013) The clinical relevance of IgA anticardiolipin and IgA anti-beta2 glycoprotein I antiphospholipid antibodies: a systematic review. Autoimmun Rev 12(3):421–425CrossRefPubMed

50.

Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T (1994) Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179(2):457–462CrossRefPubMed

51.

Amengual O, Atsumi T, Khamashta MA, Koike T, Hughes GRV (1996) Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 35(12):1239–1243CrossRefPubMed

52.

Sciascia S, Murru V, Sanna G, Roccatello D, Khamashta MA, Bertolaccini ML (2012) Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost JTH 10(12):2512–2518CrossRefPubMed

53.

Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N et al (2010) Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost JTH 8(2):237–242CrossRefPubMed

54.

Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368(11):1033–1044CrossRefPubMed

55.

Sciascia S, Bertolaccini ML (2014) Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome. Lupus 23(12):1309–1312CrossRefPubMed

56.

Sciascia S, Sanna G, Murru V, Roccatello D, Khamashta MA, Bertolaccini ML (2014) Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. Thromb Haemost 111(2):354–364CrossRefPubMed

57.

Sciascia S, Bertolaccini ML, Baldovino S, Roccatello D, Khamashta MA, Sanna G (2013) Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 12(3):426–429CrossRefPubMed

58.

Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH (2002) Autoantibodies in neuropsychiatric lupus. Autoimmunity 35(2):79–86CrossRefPubMed

59.

Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol JASN 10(2):413–424PubMed

60.

Cervera R, Vinas O, Ramos-Casals M, Font J, Garcia-Carrasco M, Siso A et al (2003) Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis 62(5):431–434CrossRefPubMedPubMedCentral

61.

Simon JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sanchez-Guerrero J (2004) Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 43(2):220–224CrossRefPubMed

62.

Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P et al (2001) Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis Off J Natl Kidney Found 37(3):490–498CrossRef

Medicine Matters Rheumatology

Abstract